Yüklüyor......
Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)
PURPOSE: Skeletal-related events (SREs) such as pathologic fracture, spinal cord compression, or the necessity for radiation or surgery to bone metastasis cause considerable morbidity, decrements in quality of life, and costs to the health care system. The results of a recent large randomized trial...
Kaydedildi:
Yayımlandı: | J Clin Oncol |
---|---|
Asıl Yazarlar: | , , , , , , , |
Materyal Türü: | Artigo |
Dil: | Inglês |
Baskı/Yayın Bilgisi: |
American Society of Clinical Oncology
2017
|
Konular: | |
Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721226/ https://ncbi.nlm.nih.gov/pubmed/29023215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.73.7437 |
Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|